Invasive Procedure

Patients with atrial fibrillation needing stroke prevention assigned to abelacimab had very low rates of bleeding during invasive procedures, according to new data from the AZALEA-TIMI 71 trial.

Invasive procedures aimed at clearing up imaging abnormalities found on lung cancer screening scans occurred infrequently, according to results published in CHEST.

Patients with stable ischemic heart disease and HF and/or left ventricular dysfunction experienced worse outcomes compared with patients who did not and may benefit more from invasive treatment strategies, researchers reported.